40165211000001102: Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags
\UK product\Virtual therapeutic moiety\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2066021000001114 Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2066041000001116 Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Is a	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has specific active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Intravenous route	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	solutioninfusion.intravenous ontology form and route	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has dispensed dose form	Infusion	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Is a	Product containing trastuzumab	false	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Trastuzumab (Zercepac) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab (Herceptin) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab (Ontruzant) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags 1 bag	Has VMP	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab (Herzuma) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier
Trastuzumab (Trazimera) 504mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	True	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2066021000001114	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2066041000001116	Trastuzumab 504mg/250ml in Sodium chloride 0.9% infusion bags (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module